https://www.selleckchem.com/pr....oducts/Azacitidine(V
0% in the 48-hour group in the PP analysis; tests for noninferiority did not reach statistical significance (difference 3.9%, 95% confidence interval [CI] -2.7 to 10.5, P value for noninferiority = 0.034). The recurrent bleeding rates within 30 days were 10.9% and 4.0% in the 24- and 48-hour groups (difference 6.9%, 95% CI -0.5 to 14.2), and the 30-day mortality rates were 5.9% and 14.1%, respectively (difference -8.2%, 95% CI -16.5 to 0.1) in the PP analysis. The transfusion requirement and the length of hospital stay were